Bausch Health reports Q4/FY 2023 results; exhibit with details not provided

Bausch Health Companies Inc.

2023-FY EPS reported -$1.62 revenue$8,757,000,000

Item 2.02 announces earnings release for quarter and year ended Dec 31, 2023.
Exhibit 99.1 containing the press release was referenced but not included in the provided text.
Unable to extract specific financial figures, segment data, or guidance changes.
No material update can be derived from the filing alone due to missing exhibit.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Bausch Health Companies Inc. reported financial results for the quarter and the year ended December 31, 2023.

Period: the quarter and the year ended December 31, 2023
Result: reported results

Exact text from the filing

Bausch Health Companies Inc. (the “Company”) issued a press release announcing results of operations for the quarter and the year ended December 31, 2023

View on SEC.gov

Browse all earnings releases →

Bausch Health Companies Inc. filing history →

Source: SEC EDGAR

accession 0000885590-24-000008

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.